Delivery Order SPE2DB20D3101-SPE2DB23FRAD0
Award Date 1/13/23
Potential Completion Date 1/17/23
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $6,768.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, with a period of performance through November 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award, valued at $10,026.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a completion date of December 23, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $3,052.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialized medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,526.34 firm fixed-price delivery order is for AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product. The contract has an ultimate completion date of January 16, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,754.84 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,862.13 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML autoinjectors. The contract has a completion date of September 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $3,052.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under an Indefinite Delivery Contract (IDC), is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has a period of performance through January 31, 2025 and uses a Firm Fixed Price pricing type. This award is not designated as a...
- This federal contract award, valued at $7,705.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a completion date of April 21, 2025. The contract type is Firm Fixed Price, and it is not designated as a set-aside. Additionally, AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $2,463.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a completion date of January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $2,475.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a completion date of February 5, 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. In addition to this specific...